Company profilePharmaceutical#774 of 1,318 in Pakistan✓ No DRAP alerts

Zeta Pharmaceuticals

Pharmaceutical company · 10 brands · 9 molecules

10 registered products 13 pharmaceutical brands 9 distinct molecules 0 DRAP alerts

Company overview

10
registered products
13
pharmaceutical brands
9
distinct molecules
0
therapeutic classes
0
DRAP alerts

Zeta Pharmaceuticals is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 10 product registrations across 9 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Zeta

11 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

11
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202511

Top molecules by brand count

Cefixime2 brands
Cholecalciferol ...... 5 Mg1 brand
Omeprazole1 brand
Ceftriaxone ...... 1000 Mg1 brand
Ceftriaxone ...... 250 Mg1 brand
Ceftriaxone ...... 500 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official12 products · Rs 124.28 – Rs 394.99
Median across source: Rs 209.19

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MASS PHARMA (PRIVATE) LIMITED holds 125 molecules not in this portfolio
000 I.UAcitretinAcitretin UspAmikacinAmlodipineAmlodipine Usp
GETZ PHARMA PAKISTAN (PVT) LTD. holds 269 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
Global Pharmaceuticals Pakistan holds 141 molecules not in this portfolio
AmikacinAmlodipineAmocycillinAmoxicillinAmoxicillin AmoxicillintrihydrateAmoxycillin

Get the full profile for Zeta

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.